The Influence of Genetic Variants on Striatal Dopamine Transporter and D2 Receptor Binding after TBI

Correction to: Journal of Cerebral Blood Flow & Metabolism (2014) 34:1328–39. doi: 10.1038/jcbfm.2014.87.

After the publication of this article, the following errors were noted in the Materials and Methods section.

On page 1330, in Figure 1 the Y-axis is erroneously labeled as % Injected Dose/kg/g and the y-data are not scaled by 0.027 MBq/mCi.

Figure 1.

Putamen [¹¹C]βCFT time activity curves (open circles) that depict the high (top) and low (bottom) ranges of [¹¹C]βCFT binding in TBI (A/C) and control (B/D) subjects. Also shown are the SRMT2 curve fits (solid lines) to the observed PET data and corresponding quantitative binding potential (BP) values. PET, positron emission tomography; TBI, traumatic brain injury.

Correction: The Y-axis label should be ‘% Injected Dose × kg/g’ and y-values should be scaled by 0.027.

The corrected figure appears below.